Standard Malaria Treatment Works Well Against Resistant Strains: Study

Standard Malaria Treatment Works Well Against Resistant Strains: Study A recent study published in the New England Journal of Medicine reveals that intravenous artesunate, the recommended treatment for malaria, remains effective even against strains resistant to it. Researchers observed similar outcomes in children with resistant malaria strains compared to those with non-resistant strains who received the same treatment. The study, involving 465 children in Uganda, supports the continued use of artesunate as the primary treatment for severe malaria.

• Intravenous artesunate is effective against malaria strains resistant to the treatment.
• Children with resistant malaria strains had similar outcomes to those with non-resistant strains when treated with artesunate.
• The study involved 465 children hospitalized in Uganda between December 2022 and October 2024.
• Children received a minimum of three doses of intravenous artesunate.
• Artesunate is recommended by the WHO as the primary treatment for severe malaria.